{"id":"https://openalex.org/W2071481852","doi":"https://doi.org/10.1111/j.1476-5381.1989.tb11821.x","title":"Neuroanatomical sites of action of 5\u2010HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse","display_name":"Neuroanatomical sites of action of 5\u2010HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse","alternate_titles":[],"publication_year":1989,"publication_date":"1989-02-01","ids":{"openalex":"https://openalex.org/W2071481852","doi":"https://doi.org/10.1111/j.1476-5381.1989.tb11821.x","mag":"2071481852","pmid":"https://pubmed.ncbi.nlm.nih.gov/2522335","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1854346"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1989.tb11821.x","doi":"https://doi.org/10.1111/j.1476-5381.1989.tb11821.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1989.tb11821.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1989.tb11821.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2071481852"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1989.tb11821.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060211915","display_name":"B. Costall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B. Costall","raw_affiliation_strings":["Postgraduate School of Studies in Pharmacology, University of Bradford","Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford, BD7 1DP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Postgraduate School of Studies in Pharmacology, University of Bradford","institution_ids":["https://openalex.org/I139894009"]},{"raw_affiliation_string":"Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford, BD7 1DP","institution_ids":["https://openalex.org/I139894009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068479398","display_name":"Maureen E Kelly","orcid":"https://orcid.org/0000-0002-0995-2425","observed_orcids":["https://orcid.org/0000-0002-0995-2425"]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M.E. Kelly","raw_affiliation_strings":["Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford, BD7 1DP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford, BD7 1DP","institution_ids":["https://openalex.org/I139894009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111913575","display_name":"R.J. Naylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"R.J. Naylor","raw_affiliation_strings":["Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford, BD7 1DP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford, BD7 1DP","institution_ids":["https://openalex.org/I139894009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108391325","display_name":"Emmanuel S. Onaivi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E.S. Onaivi","raw_affiliation_strings":["Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford, BD7 1DP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford, BD7 1DP","institution_ids":["https://openalex.org/I139894009"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111576118","display_name":"M.B. Tyers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M.B. Tyers","raw_affiliation_strings":["Neuropharmacology Department, Glaxo Group Research Ltd, Ware, SG12 0DJ","Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford, BD7 1DP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuropharmacology Department, Glaxo Group Research Ltd, Ware, SG12 0DJ","institution_ids":[]},{"raw_affiliation_string":"Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford, BD7 1DP","institution_ids":["https://openalex.org/I139894009"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111913575"],"corresponding_institution_ids":["https://openalex.org/I139894009"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":3.7759,"has_fulltext":true,"cited_by_count":122,"citation_normalized_percentile":{"value":0.94590527,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"96","issue":"2","first_page":"325","last_page":"332"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10448","display_name":"Memory and Neural Mechanisms","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht3-receptor","display_name":"5-HT3 receptor","score":0.8199999928474426},{"id":"https://openalex.org/keywords/5-ht3-receptor-agonist","display_name":"5-HT3 receptor agonist","score":0.7260000109672546},{"id":"https://openalex.org/keywords/5-ht3-receptor-antagonists","display_name":"5-HT3 receptor antagonists","score":0.9900000095367432},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":0.9150000214576721},{"id":"https://openalex.org/keywords/tropisetron","display_name":"tropisetron","score":0.9990000128746033},{"id":"https://openalex.org/keywords/aversive-behavior","display_name":"aversive behavior","score":0.9509999752044678},{"id":"https://openalex.org/keywords/light-dark-test","display_name":"light/dark test","score":0.40400001406669617},{"id":"https://openalex.org/keywords/dorsal-raphe-nucleus","display_name":"dorsal raphe nucleus","score":0.9739999771118164},{"id":"https://openalex.org/keywords/median-raphe-nucleus","display_name":"median raphe nucleus","score":0.9980000257492065},{"id":"https://openalex.org/keywords/amygdala","display_name":"amygdala","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.9739999771118164},{"id":"https://openalex.org/keywords/caudate-putamen","display_name":"caudate-putamen","score":0.9980000257492065},{"id":"https://openalex.org/keywords/exploratory-behavior","display_name":"exploratory behavior","score":0.7310000061988831}],"concepts":[{"id":"https://openalex.org/C32610206","wikidata":"https://www.wikidata.org/wiki/Q5298804","display_name":"Dorsal raphe nucleus","level":5,"score":0.7480952143669128},{"id":"https://openalex.org/C2776570665","wikidata":"https://www.wikidata.org/wiki/Q6806127","display_name":"Median raphe nucleus","level":5,"score":0.6995264887809753},{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.6776033639907837},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.6686651706695557},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6075051426887512},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.5713074803352356},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5482063293457031},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5135586261749268},{"id":"https://openalex.org/C2909992730","wikidata":"https://www.wikidata.org/wiki/Q7455050","display_name":"Serotonin Agonist","level":5,"score":0.4601467549800873},{"id":"https://openalex.org/C2777865548","wikidata":"https://www.wikidata.org/wiki/Q2061493","display_name":"Raphe nuclei","level":5,"score":0.44863221049308777},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44261157512664795},{"id":"https://openalex.org/C2777426569","wikidata":"https://www.wikidata.org/wiki/Q5062126","display_name":"Central nucleus of the amygdala","level":3,"score":0.44042202830314636},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4152637720108032},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3677939176559448},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.3548165559768677},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3096363842487335},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2653302252292633},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.23030298948287964},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.22104066610336304},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1705015003681183}],"mesh":[{"descriptor_ui":"D000077526","descriptor_name":"Tropisetron","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005106","descriptor_name":"Exploratory Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017294","descriptor_name":"Ondansetron","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1989.tb11821.x","doi":"https://doi.org/10.1111/j.1476-5381.1989.tb11821.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1989.tb11821.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1989.tb11821.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:2522335","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2522335","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1854346","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1854346/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1989.tb11821.x","doi":"https://doi.org/10.1111/j.1476-5381.1989.tb11821.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1989.tb11821.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1989.tb11821.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2071481852.pdf","grobid_xml":"https://content.openalex.org/works/W2071481852.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1030949942","https://openalex.org/W1966385194","https://openalex.org/W1969811636","https://openalex.org/W1977283820","https://openalex.org/W1981935827","https://openalex.org/W1995604771","https://openalex.org/W2002312324","https://openalex.org/W2010163969","https://openalex.org/W2013082402","https://openalex.org/W2013600778","https://openalex.org/W2019012629","https://openalex.org/W2019842287","https://openalex.org/W2020195097","https://openalex.org/W2021092705","https://openalex.org/W2035193405","https://openalex.org/W2046100639","https://openalex.org/W2056088791","https://openalex.org/W2070846125","https://openalex.org/W2081503035","https://openalex.org/W2092456347","https://openalex.org/W2133144591","https://openalex.org/W2410328866","https://openalex.org/W4253787153","https://openalex.org/W7006087495"],"related_works":["https://openalex.org/W2001549694","https://openalex.org/W2028560297","https://openalex.org/W2047290291","https://openalex.org/W1994179916","https://openalex.org/W2059819543","https://openalex.org/W2063807129","https://openalex.org/W1986291745","https://openalex.org/W2625117031","https://openalex.org/W2036747602","https://openalex.org/W4245836110"],"abstract_inverted_index":{"1.":[0],"The":[1,99,173,224],"cerebral":[2,271],"topography":[3,272],"of":[4,7,12,73,88,101,123,175,254,273,275,287],"the":[5,10,13,30,43,49,74,82,86,92,95,114,121,128,137,143,147,152,160,169,176,183,190,194,200,205,213,220,237,257,268,270,290,305],"action":[6,11,274],"diazepam":[8,102,124,288,298],"and":[9,19,45,64,78,85,108,118,120,150,156,187,203,209,227,241,277,294],"5-hydroxytryptamine":[14],"5-HT3":[15,177,225],"receptor":[16],"antagonists":[17,228],"GR38032F":[18,105,276],"ICS":[20,109,278],"205-930":[21,110,279],"in":[22,29,57,81,159,168,212,219,246,267,280,289],"attenuating":[23,281],"an":[24,133,282],"aversive":[25,134,283],"response":[26,135,284],"was":[27],"studied":[28],"mouse.":[31],"2.":[32],"Mice":[33],"which":[34],"had":[35],"been":[36],"cannulated":[37],"to":[38,94,136,197],"allow":[39],"drug":[40],"injection":[41,100,122,174,235,253],"into":[42,113,127,146,182,199,236,256],"dorsal":[44,115,184,291],"median":[46,129,238,306],"raphe":[47,116,130,185,239,292,307],"nuclei,":[48],"amygdala,":[50,119],"nucleus":[51,117,186,240,258,293],"accumbens":[52,259],"or":[53,231,252,260],"caudate-putamen":[54],"were":[55,71,166,243],"placed":[56],"a":[58],"two":[59,83],"compartment":[60],"black":[61,96,148,170,201,214],"(dimly":[62],"illuminated)":[63,67],"white":[65,93,140,161,221],"(brightly":[66],"test":[68],"box.":[69],"Measurements":[70],"made":[72],"time":[75,153,195,206],"spent,":[76,154,207],"rearing":[77],"line":[79,157,210],"crossings":[80,158,211],"sections":[84],"latency":[87],"initial":[89,144],"movement":[90,145],"from":[91],"area.":[97,162,222],"3.":[98],"(0.1-10":[103,125,180],"ng),":[104],"(0.01-1.0":[106],"ng)":[107,112,126,181],"(1.0-10":[111],"nucleus,":[131],"reduced":[132],"brightly":[138],"illuminated":[139],"area,":[141],"delaying":[142],"section":[149,202],"increasing":[151,204],"rearings":[155,208],"Concomitantly":[163],"such":[164,217],"activities":[165,218],"decreased":[167],"section.":[171],"4.":[172],"agonist":[178,226],"2-methyl-5-hydroxytryptamine":[179],"amygdala":[188,295],"caused":[189],"opposite":[191],"response,":[192],"decreasing":[193,216],"taken":[196],"move":[198],"section,":[215],"5.":[223],"showed":[229],"little":[230],"no":[232,244],"effect":[233],"following":[234,249],"there":[242],"changes":[245],"exploratory":[247],"behaviour":[248],"their":[250],"injection,":[251],"diazepam,":[255],"caudate-putamen.":[261],"6.":[262],"It":[263],"is":[264],"concluded":[265],"that":[266,286,297],"mouse":[269],"follows":[285],"but":[296],"may":[299],"have":[300],"additional":[301],"effects":[302],"mediated":[303],"via":[304],"nucleus.":[308]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2071481852","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
